PMID- 36976424 OWN - NLM STAT- MEDLINE DCOM- 20230626 LR - 20230626 IS - 1615-2573 (Electronic) IS - 0910-8327 (Linking) VI - 38 IP - 8 DP - 2023 Aug TI - Acute coronary syndrome in very elderly patients-a real-world experience. PG - 1019-1027 LID - 10.1007/s00380-023-02260-x [doi] AB - Very elderly population constitutes an increasingly larger proportion of patients admitted for acute coronary syndromes (ACS). Notably, age represents both a proxy of frailty and an exclusion criterion in clinical randomized trials, which probably contributes to lack of data and undertreatment of real-world elderly patients. The aim of the study is to describe patterns of treatment and outcome of very elderly patients with ACS. All consecutive patients aged >/= 80 years old (yo) admitted between January 2017 and December 2019 with ACS were included. The primary endpoint was in-hospital occurrence of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, new onset cardiogenic shock, definite/probable stent thrombosis, and ischemic stroke. The secondary endpoints were in-hospital incidence of Thrombolysis in Myocardial Infarction (TIMI) major/minor bleedings, contrast-induced nephropathy (CIN), six-month all-cause mortality, and unplanned readmission. One hundred ninety-three patients (mean age 84.1 +/- 3.5 yo, 46% females) were included, of whom 86 (44.6%), 79 (40.9%), and 28 (14.5%) presented with ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina (UA), respectively. The vast majority of patients received an invasive strategy, with 92.7% undergoing coronary angiography and 84.4% to percutaneous coronary intervention (PCI). Aspirin was administered to 180 (93.3%) patients, clopidogrel to 89 (46.1%) patients, and ticagrelor to 85 (44%) patients. In-hospital MACE occurred in 29 patients (15.0%), whereas 3 (1.6%) and 12 patients (7.2%) experienced in-hospital TIMI major and TIMI minor bleeding, respectively. Of the overall population, 177 (91.7%) were discharged alive. After discharge, 11 patients (6.2%) died of all-cause death, whereas 42 patients (23.7%) required a new hospitalization within six months. Invasive strategy of ACS in elderly patients seems safe and effective. Six-month new hospitalization appears inevitably related to age. CI - (c) 2023. Springer Nature Japan KK, part of Springer Nature. FAU - Bianco, Matteo AU - Bianco M AD - Division of Cardiology, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy. FAU - Mottola, Filiberto Fausto AU - Mottola FF AD - Chair of Cardiology, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli"-Monaldi Hospital, Naples, Italy. FAU - Cerrato, Enrico AU - Cerrato E AD - Division of Cardiology, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy. FAU - Giordana, Francesca AU - Giordana F AD - Division of Cardiology, S. Croce and Carle Hospital, Via Michele Coppino, 26, 12100, Cuneo, Italy. FAU - Cinconze, Sebastian AU - Cinconze S AD - Division of Cardiology, S. Croce and Carle Hospital, Via Michele Coppino, 26, 12100, Cuneo, Italy. FAU - Baralis, Giorgio AU - Baralis G AD - Division of Cardiology, S. Croce and Carle Hospital, Via Michele Coppino, 26, 12100, Cuneo, Italy. FAU - Verra, Alison AU - Verra A AD - Division of Cardiology, S. Croce and Carle Hospital, Via Michele Coppino, 26, 12100, Cuneo, Italy. FAU - Musumeci, Giuseppe AU - Musumeci G AD - Division of Cardiology, Ordine Mauriziano Di Torino Hospital, Turin, Italy. FAU - Rossini, Roberta AU - Rossini R AD - Division of Cardiology, S. Croce and Carle Hospital, Via Michele Coppino, 26, 12100, Cuneo, Italy. roberta.rossini2@gmail.com. LA - eng PT - Journal Article DEP - 20230328 PL - Japan TA - Heart Vessels JT - Heart and vessels JID - 8511258 RN - A74586SNO7 (Clopidogrel) RN - R16CO5Y76E (Aspirin) RN - 0 (Platelet Aggregation Inhibitors) SB - IM MH - Female MH - Humans MH - Aged MH - Aged, 80 and over MH - Male MH - *Acute Coronary Syndrome/diagnosis/therapy/complications MH - *Percutaneous Coronary Intervention/adverse effects MH - *Myocardial Infarction/complications MH - Clopidogrel/adverse effects MH - Aspirin/adverse effects MH - Hemorrhage/chemically induced/epidemiology MH - *Non-ST Elevated Myocardial Infarction/diagnosis/therapy MH - Treatment Outcome MH - Platelet Aggregation Inhibitors/adverse effects OTO - NOTNLM OT - Acute coronary syndromes OT - Percutaneous coronary intervention OT - Real world OT - Very elderly EDAT- 2023/03/29 06:00 MHDA- 2023/06/26 06:42 CRDT- 2023/03/28 11:19 PHST- 2022/10/06 00:00 [received] PHST- 2023/03/08 00:00 [accepted] PHST- 2023/06/26 06:42 [medline] PHST- 2023/03/29 06:00 [pubmed] PHST- 2023/03/28 11:19 [entrez] AID - 10.1007/s00380-023-02260-x [pii] AID - 10.1007/s00380-023-02260-x [doi] PST - ppublish SO - Heart Vessels. 2023 Aug;38(8):1019-1027. doi: 10.1007/s00380-023-02260-x. Epub 2023 Mar 28.